Alimera sciences inc share price
WebApr 14, 2024 · Alimera Sciences Inc (ALIM) stock is higher by 9.95% while the S&P 500 has fallen -0.53% as of 12:03 PM on Friday, Apr 14. ALIM is up $0.20 from the previous closing price of $1.98 on volume of 18,143 shares. Over the past year the S&P 500 is lower by -6.11% while ALIM has fallen -64.55%. ALIM lost -$2.59 per share the over the last 12 … WebAlimera Sciences, Inc. (ALIM) Stock Price, News, Quote & History - Yahoo Finance Alimera Sciences, Inc. (ALIM) NasdaqGM - NasdaqGM Delayed Price. Currency in … Alimera Sciences, Inc. 6310 Town Square Suite 400 Alpharetta, GA 30005 United … Find out all the key statistics for Alimera Sciences, Inc. (ALIM), including … NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow. Visitors trend … Find the latest Alimera Sciences, Inc. (ALIM) stock discussion in Yahoo … Find out the direct holders, institutional holders and mutual fund holders for … See Alimera Sciences, Inc. (ALIM) stock analyst estimates, including earnings … Get the detailed quarterly/annual income statement for Alimera Sciences, Inc. … Get the latest Alimera Sciences, Inc. (ALIM) stock news and headlines to help you in … Find the latest Alimera Sciences, Inc. (ALIM) stock quote, history, news and … The latest news and headlines from Yahoo! News. Get breaking news stories and in …
Alimera sciences inc share price
Did you know?
WebMar 17, 2024 · Key statistics Alimera Sciences Inc (ALIM:NMQ) set a new 52-week low during today's trading session when it reached 1.57. Over this period, the share price is down -70.54%. 52-week range... WebOn Friday morning 03/31/2024 the Alimera Sciences Inc Registered Shs share started trading at the price of $1.93. Compared to the closing price on Thursday 03/30/2024 on NAS of $1.78, this is a ...
WebShares Market Cap Price Delayed by 20 minutes Alimera Sciences is a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer. IR Contacts Subscribe to News Alerts RSS Feed COMPANY PROFILE 6310 Town Square, Suite … WebMar 23, 2024 · ALIMERA SCIENCES, INC. Capi. / Sales 2024. Capi. / Sales 2024. Alimera Sciences, Inc. is a pharmaceutical company. The Company is engaged in commercialization and development of prescription ophthalmic pharmaceuticals. The Company focuses on diseases affecting the retina. The Company’s commercial …
WebAlimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals. It operates through United States, internationally, and Operating Cost segments. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that ... WebApr 10, 2024 · Sight Sciences Inc Stock Price History. Sight Sciences Inc’s price is currently down 0.8% so far this month. During the month of April, Sight Sciences Inc’s stock price has reached a high of $9.03 and a low of $7.79. Over the last year, Sight Sciences Inc has hit prices as high as $15.30 and as low as $5.35. Year to date, Sight Sciences …
WebShares Market Cap Price Delayed by 20 minutes Alimera Sciences is a global pharmaceutical company whose mission is to be invaluable to patients, physicians and …
WebWelcome to Alimera. We’re Glad You’re Here. We are a company of people with a passion for protecting the retina to preserve vision. Every day we have the opportunity to change a life, so we use our knowledge, innovative treatments and collaboration with providers, patients and partners to get it done. do nsaids help with swellingWebOct 30, 2024 · A week ago, Alimera Sciences, Inc. (NASDAQ:ALIM) came out with a strong set of third-quarter numbers that could potentially lead to a re-rate of the stock. The results overall were pretty... do nsaids thin out your bloodWebAlimera Sciences Inc - Company Profile and News - Bloomberg Markets Bloomberg Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately... city of gaithersburg md gisWebAug 17, 2024 · Alimera Sciences Inc. shares closed today 15.9% lower than it did at the end of yesterday.The stock is currently up 45.7% year-to-date, up 0.9% over the past 12 months, and down 75.9% over the ... city of gaithersburg mapWebApr 14, 2024 · Gilead Sciences Inc. (NASDAQ:GILD) shares, rose in value on Friday, April 14, with the stock price down by -1.36% to the previous day’s close as strong demand from buyers drove the stock to $82.14. Actively observing the price movement in the recent trading, the stock is buoying the session at $83.27, falling within a range of $81.925 and … do nsaids interact with warfarinWebMar 31, 2024 · Alimera Sciences, Inc. reported earnings results for the full year ended December 31, 2024. For the full year, the company reported revenue was USD 54.13 million compared to USD 59.03 million a year ago. Net loss was USD 18.11 million compared to USD 4.37 million a year ago. do nsaids increase inrWebMar 17, 2024 · Alimera Sciences, Inc. Common Stock (ALIM) Stock Price, Quote, News & History Nasdaq Alimera Sciences, Inc. Common Stock (ALIM) Add to Watchlist Add to … city of gaithersburg hdc